Sporadic Cryptosporidiosis Case-Control Study with Genotyping
Paul R. Hunter*
, Sara Hughes†, Sarah Woodhouse†, Qutub Syed†, Neville Q. Verlander‡, Rachel M. Chalmers§, Kenton L. Morgan¶, Gordon Nichols†, Nick Beeching#, and Keith Osborn**
Author affiliations: *University of East Anglia, Norwich United Kingdom; †Communicable Disease Surveillance Centre – North West, Chester, United Kingdom; ‡Communicable Disease Surveillance Centre, London, United Kingdom; §Singleton Hospital, Swansea, United Kingdom; ¶University of Liverpool, Liverpool, United Kingdom; #Liverpool School of Tropical Medicine, Liverpool, United Kingdom; and; **United Utilities, Warrington, United Kingdom
Figure. A, duration of illness, all patients. B, duration of illness for Cryptosporidium hominis and C. parvum patients.
Page created: June 16, 2011
Page updated: June 16, 2011
Page reviewed: June 16, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.